Photobiomodulation Therapy for Parkinson’s Disease

This chapter explores the potential of photobiomodulation (PBM) therapy for Parkinson's disease, providing an overview of the condition, discussing relevant animal models, and examining the therapeutic approach in both animal studies and human clinical trials. Section 10.1 introduces Parkinson's disease, a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons, leading to motor and non-motor symptoms that significantly impact patients' quality of life. Section 10.2 discusses various animal models of Parkinson's disease, which play a crucial role in advancing our understanding of the disorder's underlying mechanisms and testing potential therapeutic interventions, such as PBM. Section 3 focuses on PBM therapy for Parkinson's disease, with subsections discussing its application in animal models (10.3.1) and human clinical studies (10.3.2). This section provides a comprehensive overview of the current state of research, highlighting the potential benefits of PBM therapy in alleviating motor symptoms, promoting neuroprotection, and reducing neuroinflammation.